Onward Therapeutics Partners with Institut du Cancer for Major Onco-Metabolism Licensing Deal Onward Therapeutics has signed a worldwide license agreement with Institut du Cancer de Montpellier to advance their innovative Onco-Metabolism program, aimed at enhancing cancer treatment.

Onward Therapeutics Partners with Institut du Cancer for Major Onco-Metabolism Licensing Deal #Switzerland #Onward_Therapeutics #Epalinges #Institut_du_Cancer #Onco-Metabolism